Corvus Pharmaceuticals, Inc. (CRVS)
13.93
-0.46
(-3.20%)
USD |
NASDAQ |
Sep 08, 16:00
13.93
0.00 (0.00%)
Pre-Market: 08:06
Corvus Pharmaceuticals Debt to Equity Ratio : 0.0032 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0032 |
| March 31, 2026 | 0.0035 |
| December 31, 2025 | 0.0153 |
| September 30, 2025 | 0.0141 |
| June 30, 2025 | 0.0135 |
| March 31, 2025 | 0.0234 |
| December 31, 2024 | 0.0345 |
| September 30, 2024 | 0.0285 |
| June 30, 2024 | 0.0137 |
| March 31, 2024 | 0.0312 |
| December 31, 2023 | 0.0355 |
| September 30, 2023 | 0.0382 |
| June 30, 2023 | 0.0404 |
| March 31, 2023 | 0.0471 |
| December 31, 2022 | 0.0464 |
| September 30, 2022 | 0.0444 |
| June 30, 2022 | 0.039 |
| March 31, 2022 | 0.0378 |
| December 31, 2021 | 0.0375 |
| September 30, 2021 | 0.0369 |
| June 30, 2021 | 0.0185 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0217 |
| December 31, 2020 | 0.032 |
| September 30, 2020 | 0.0599 |
| June 30, 2020 | 0.0543 |
| March 31, 2020 | 0.0496 |
| December 31, 2019 | 0.0448 |
| September 30, 2019 | 0.0421 |
| June 30, 2019 | 0.0399 |
| March 31, 2019 | 0.0374 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 239.27M |
| Total Liabilities (Quarterly) | 13.95M |
| Shareholders Equity (Quarterly) | 225.33M |
| Current Ratio | 16.16 |
| Net Debt Paydown Yield | 0.01% |